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Highlights 
 
 Alpha source connectivity was similarly reduced in both mild cognitive impairment due 
to Alzheimer’s (ADMCI) and Parkinson’s (PDMCI) disease. 
 Delta source connectivity was normal in those groups.  
 Alpha source connectivity might reflect (common) cholinergic impairment in ADMCI 
and PDMCI. 
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Abstract 
Objective:  This study tested the hypothesis that markers of functional cortical source 
connectivity of resting state eyes-closed electroencephalographic (rsEEG) rhythms may be 
abnormal in subjects with mild cognitive impairment due to Alzheimer’s (ADMCI) and 
Parkinson’s (PDMCI) diseases compared to healthy elderly subjects (Nold). 
Methods: rsEEG data had been collected in ADMCI, PDMCI, and Nold subjects (N=75 for any 
group). eLORETA freeware estimated functional lagged linear connectivity (LLC) from rsEEG 
cortical sources. Area under receiver operating characteristic (AUROC) curve indexed the 
accuracy in the classification of Nold and MCI individuals. 
Results: Posterior interhemispheric and widespread intrahemispheric alpha LLC solutions 
were abnormally lower in both MCI groups compared to the Nold group. At the individual 
level, AUROC curves of LLC solutions in posterior alpha sources exhibited moderate accuracies 
(0.70-0.72) in the discrimination of Nold vs. ADMCI-PDMCI individuals. No differences in the 
LLC solutions were found between the two MCI groups. 
Conclusions: These findings unveil similar abnormalities in functional cortical connectivity 
estimated in widespread alpha sources in ADMCI and PDMCI. This was true at both group and 
individual levels. 
Significance: The similar abnormality of alpha source connectivity in ADMCI and PDMCI 
subjects might reflect common cholinergic impairment. 
 
  
 
4 
 
Introduction 
About 50-70% of 46 million of cases of dementia worldwide are due to Alzheimer’s 
(ADD) and Parkinson’s (PDD) neurodegenerative diseases across aging (Prince et al., 2015). 
ADD typically presents a major amnesic syndrome and minor linguistic, visuospatial, and visual 
disease variants (Dubois et al., 2014). PDD manifest attentional, verbal, and executive 
cognitive deficits in association with motor manifestations such as akinesia, tremor, postural 
instability, and rigidity (Aarsland et al., 2003; Buter et al., 2008; Dubois and Pillon, 1996; Emre 
et al., 2007; Huber et al., 1989; Hughes et al., 2000; Levy et al., 2000; Walker et al., 2015; 
Wolters, 2001). These cognitive deficits can be observed before the diagnosis of dementia (i.e. 
major cognitive disorders and disabilities) in the clinical condition called mild cognitive 
impairment (MCI), which is considered as a pre-dementia stage of neurodegenerative 
disorders. 
Previous studies have shown that resting state eyes-closed electroencephalographic 
(rsEEG) rhythms may probe the neurophysiological “reserve” in patients with ADMCI and 
PDMCI, defined as the residual ability of the brain to ensure (1) the synchronization of neural 
activity at different spatial scales and frequencies from small cellular populations to large 
regions and (2) the coordination of that synchronization across subcortical and cortical neural 
networks (Babiloni et al., 2016a; 2017). The latter might be especially relevant to understand 
the pathophysiological mechanisms underlying different neurodegenerative disorders, as 
human cognition is based on a coordinated neurotransmission within large-scale networks 
(D’Amelio and Rossini, 2012; Pievani et al., 2011).  
As far as the “functional cortical connectivity” markers are concerned, it has been 
reported that compared with normal elderly (Nold) subjects, ADD patients point to lower 
spectral coherence between electrode pairs in posterior alpha (8-12 Hz) and beta (13-20 Hz) 
rhythms (Adler et al., 2003; Anghinah et al., 2000; Besthorn et al., 1994a; Dunkin et al., 1994; 
Fonseca et al., 2013, 2011, Jelic et al., 2000, 1996; Knott et al., 2000; Leuchter et al., 1994, 
1987, 1992; Locatelli et al., 1998; Pogarell et al., 2005; Sloan et al., 1994). However, these 
effects are topographically variable being observed in temporo-parieto-occipital electrode 
pairs in some studies (Adler et al., 2003; Locatelli et al., 1998; Jelic et al., 1996, 2000) yet in 
other studies in frontocentral electrode pairs (Besthorn et al., 1994; Fonseca et al., 2013; 
Leucther et al., 1994). Furthermore, some studies report a decrease of rsEEG coherence at low 
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frequencies, especially at central electrodes in the theta band (Adler et al., 2003; Knott et al., 
2000). Other studies report an increase in widespread delta coherences (Babiloni et al., 2010) 
or a quite complex topographical pattern of coherence increases and decreases (Sankari et al., 
2011). Finally, studies using alternative techniques measuring rsEEG functional coupling show 
a decrement of synchronization likelihood in frontoparietal alpha rhythms in ADD patients and 
those with the pre-dementia stage of amnesic mild cognitive impairment (aMCI) compared 
with Nold subjects (Babiloni et al., 2004, 2006a). Furthermore, directed transfer function (DTF) 
exhibited a lower flow of information between EEG signals in alpha and beta from parietal to 
frontal electrodes in ADD and aMCI patients compared with Nold subjects (Babiloni et al., 
2009; Dauwels et al., 2010, 2009). Moreover, Canuet et al. (2012) reported a decrease in alpha 
2 lagged phase synchronization between temporal and parietal electrodes in ADD patients 
compared with Nold subjects, and an increase in low frequency rsEEG rhythms, specifically in 
the theta band, between and within hemispheres. Nevertheless, in aMCI compared to Nold 
subjects, the opposite result was found, i.e. decreased phase lag index in the delta and theta 
rhythms within the frontal and between the frontal and temporal/parietal areas, with more 
pronounced effects 1 year later (Tóth et al., 2014). 
In PD individuals, abnormal “functional cortical connectivity” was consistently revealed 
by rsEEG coherence between electrode pairs. Compared to Nold subjects, PD patients showed 
lower local intrahemispheric parietal alpha coherence (Moazami-Goudarzi et al., 2008). 
Furthermore, intrahemispheric cortico-cortical frontoparietal alpha and beta coherences 
were positively correlated with the severity of PD motor symptoms in the patients (Silberstein 
et al., 2005). Both L-dopa regimen and electrical stimulation of subthalamic nucleus reduced 
those coherences in association with an improvement of motor symptoms (Silberstein et al., 
2005). Other evidence revealed a positive correlation between PD duration and beta 
coherence between rsEEG rhythms recorded in supplementary motor and primary motor 
areas (Pollok et al., 2013). 
Concerning the relationship between “functional cortical connectivity” and cognition, 
PD patients with cognitive deficits demonstrate a positive correlation between decreased 
intrahemispheric frontoparietal alpha coherence and executive dysfunctions(Teramoto et al., 
2016). Furthermore, PDD patients exhibit greater interhemispheric frontal alpha-beta and 
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intrahemispheric fronto-occipital beta coherences than ADD patients do (Fonseca et al., 
2013).  
Recently, we have introduced a procedure combining (1) a source estimation 
technique called exact low-resolution brain electromagnetic tomography (Pascual-Marqui, 
2007a) and (2) an analysis of rsEEG rhythms based on the “individual alpha frequency peak” 
(IAF; Klimesch, 1999; Klimesch et al., 1998, 1996). With this approach, we have tested the 
hypothesis that eLORETA source activity of scalp rsEEG rhythms might show differences in 
markers of cortical neural “synchronization/desynchronization” obtained in ADMCI and 
PDMCI patients compared with Nold subjects (Babiloni et al., 2017). As main findings, 
abnormalities in IAF showed abnormal lower frequencies in the PDMCI than the ADMCI group 
(Babiloni et al., 2017). Furthermore, compared with Nold subjects, the ADMCI and PDMCI 
patients showed robust abnormalities in rsEEG cortical source activity with some differences 
even between the diseased groups. Compared with Nold subjects, posterior alpha source 
activities were more abnormal in the ADMCI than the PDMCI group, while the parietal delta 
source activities were more abnormal in the PDMCI than the ADMCI group (Babiloni et al., 
2017). Finally, the parietal delta and alpha sources correlated with the mini-mental evaluation 
(MMSE) score of global cognition and correctly classified (area under the receiver operating 
characteristic, AUROC, curve = 0.77-0.79) the Nold and diseased individuals (Babiloni et al., 
2017). 
As mentioned above, the “synchronization/desynchronization” of large cortical neural 
populations and the coordination of that synchronization across brain networks as a sign of 
“connectivity” may reveal complementary (no redundant) aspects of the neurophysiological 
“reserve” probed by rsEEG rhythms (Babiloni et al., 2016a). For this reason, the present 
retrospective study re-analyzed the original rsEEG database used in the mentioned reference 
investigation (Babiloni et al., 2017) to extract and compare markers of “functional cortical 
connectivity” in delta and alpha sources in Nold, ADMCI, and PDMCI subjects. Keeping in mind 
the previous reference results based on “synchronization/desynchronization” markers 
(Babiloni et al., 2017), the present study tested the primary hypothesis that compared to Nold 
subjects, ADMCI and PDMCI patients may show abnormal rsEEG cortical source connectivity 
at the group and the individual level. In a more exploratory way, we also tested the potential 
differences in the rsEEG cortical source connectivity between ADMCI and PDMCI subjects. To 
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facilitate the comparison with the results of the previous investigation (Babiloni et al., 2017), 
the present study adopted a similar data analysis design. ANOVAs tested differences in LLC 
solutions between pairs of groups (i.e., Nold, ADMCI, and PDMCI). Furthermore, correlation 
and classification (i.e., AUROC curve analysis) procedures tested if the LLC solutions showing 
differences between the groups conveyed information contents at the individual level. The 
main expectation was that compared with rsEEG markers of 
“synchronization/desynchronization”, those of “functional cortical connectivity” might enrich 
the clinical neurophysiological model of the prodromal stage of AD and PD compared with 
controls with normal cognition. 
 
Materials and Methods 
Details on the subjects, diagnostic criteria, rsEEG recording, and preliminary data 
analysis were reported in detail in the reference paper (Babiloni et al., 2017). However, we 
will provide a short description of those methodological procedures for readers’ convenience 
in the following sections. 
 
Subjects and diagnostic criteria 
As we mentioned in the Introduction section, the present study re-analyzed the rsEEG 
data of an international archive, formed by clinical, neuropsychological, and 
electrophysiological data in 75 Nold, 75 ADMCI, and 75 PDMCI, subjects (Babiloni et al., 2017). 
The three groups of subjects (i.e. PDMCI, ADMCI, and Nold) were carefully matched for age, 
gender, and education. The two groups of MCI patients were also carefully matched for the 
MMSE score (Folstein et al., 1975). Table 1 reports details of the above variables in the three 
groups. All subjects gave their written informed consensus to the use of the clinical, 
neuropsychological, and any other data collected from their persons for academic scientific 
studies with the condition that their identity was secured.  
Insert here Table 1 
The inclusion criteria for the enrollment of the ADMCI patients were (1) age between 
55 and 90 years; (2) complaints of memory deficits by the patient (and confirmed by a relative) 
or a relative; (3) MMSE score ≥ 24, overall Clinical Dementia Rating (CDR; Morris, 1993) score 
of 0.5; (4) score on the logical memory test (Wechsler, 1987) of 1.5 standard deviation (SD) 
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lower than the age-adjusted mean; (5) 15-item Geriatric Depression Scale (GDS; Brown and 
Schinka, 2005) score ≤ 5; and (6) modified Hachinski ischemia (Rosen et al., 1980) score ≤ 4 
and at least 5 years of education. The MCI status could be single or multi-domain.  
The status of the ADMCI was based on the “positivity” to one or more of the following 
biomarkers: Aβ1-42/phospho-tau in the cerebrospinal fluid (CSF), Fluorodeoxyglucose 
positron emission tomography (FDG-PET) mapping of hippocampus, parietal, temporal, and 
posterior cingulate regions, and structural magnetic resonance imaging (MRI) of 
hippocampus, parietal, temporal, and posterior cingulate regions (Albert et al., 2011). The 
“positivity” was based on the judgement of “abnormality” of the readout given by physicians 
in charge for the diagnosis of patients, according to the local diagnostic routine of the 
participating clinical Units. The judgement was done before the planning of the present 
retrospective study, so it can be considered as “blind”. 
Exclusion criteria for the ADMCI patients were other significant neurological, systemic 
or psychiatric illness, mixed neurodegenerative diseases, enrolment in a clinical trial with 
experimental drugs, the use of antidepressant drugs with anticholinergic side effects, high 
dose of neuroleptics or chronic sedatives or hypnotics, antiparkinsonian medication and the 
use of narcotic analgesics. Of note, the use of cholinesterase inhibitors and Memantine was 
allowed. 
All ADMCI subjects underwent a battery of neuropsychological tests (for details see 
(Babiloni et al., 2017). 
The diagnosis of PD was based on a standard clinical assessment of tremor, rigidity, 
bradykinesia, and postural instability without major cognitive deficits for 12 months in 
accordance with the UK PD Brain Bank Criteria (Gelb et al., 1999). As measures of severity of 
the motor disability, the Hoehn and Yahr stage (Hoehn and Yahr, 1967), and the Unified 
Parkinson Disease Rating Scale-III (UPDRS-III; Fahn and Elton, 1987) for extrapyramidal 
symptoms, were used.  
The status of the PDMCI was based on the Diagnostic Criteria for Mild Cognitive 
Impairment in Parkinson’s Disease (Litvan et al., 2011). The inclusion criteria comprised: (1) a 
diagnosis of PD as specified above; (2) a gradual decline, in the context of an established PD, 
in the cognitive status reported by either the patient or informant, or observed by the 
clinicians; (3) cognitive deficits not sufficient to interfere significantly with functional 
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independence in the activities of the daily life, although slight difficulties on complex 
functional tasks may be present. On the basis of clinical features and neuroradiological 
findings, the exclusion criteria for PDMCI included the following forms of parkinsonism: (1) 
Dementia with Lewy Body (Geser et al., 2005; McKeith et al., 2005, 1996), (2) drug-induced 
parkinsonism, (3) cerebrovascular parkinsonism, (4) atypical parkinsonism with absent or 
minimal responses to antiparkinsonian drugs, and (5) mixed neurodegenerative diseases. 
All PDMCI subjects also underwent a battery of clinical scales and neuropsychological 
tests (for details see (Babiloni et al., 2017). 
All Nold subjects underwent a cognitive screening (including MMSE and GDS) as well 
as physical and neurological examinations to exclude any dementia or major cognitive deficit 
or psychiatric disorder.  
 
rsEEG recordings and preliminary data analysis 
The rsEEG data were recorded while subjects kept their eyes closed in a relaxed state, 
not moving or talking. About five minutes of rsEEG data were recorded (128 Hz or higher 
sampling rate, with related antialiasing bandpass between 0.01 Hz and 100 Hz) from 19 scalp 
electrodes positioned according to the 10–20 System (i.e. Fp1, Fp2, F7, F3, Fz, F4, F8, T3, C3, 
Cz, C4, T4, T5, P3, Pz, P4, T6, O1, and O2). A ground electrode was located in frontal region. 
Electrodes impedances were kept below 5 Kohm. Horizontal and vertical electro-oculographic 
activities (0.3-70 Hz bandpass) were also recorded to monitor blinking and eye movements. 
Linked earlobe reference electrode was preferred, but not mandatory to take into account the 
methodological facilities and standard internal protocols of the clinical recording units (137 
subjects out of 225 subjects were recorded with linked earlobe reference, while the others 
with cephalic reference).  
The rsEEG data were centrally analyzed in blind about the subjects’ diagnosis at 
University of Rome “La Sapienza”.  Specifically, the were divided into segments of 2 seconds 
and analyzed off-line. The epochs affected by any physiological (ocular, muscular, head 
movements) or non-physiological (bad contact electrode-scalp) artifacts were preliminarily 
identified by an automatic computerized procedure (Moretti et al., 2003). Two independent 
experimenters manually checked and (dis)confirmed the artifact-free rsEEG epochs, before 
successive analyses. 
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A standard digital FFT-based power spectrum analysis (Welch technique, Hanning 
windowing function, no phase shift) computed the power density of scalp rsEEG rhythms with 
0.5 Hz of frequency resolution.  
The frequency bands of interest were individually identified based on the following 
frequency landmarks: the transition frequency (TF) and the IAF. In the EEG power density 
spectrum, the TF marked the transition frequency between the theta and alpha bands, defined 
as the minimum of the rsEEG power density between 3 and 8 Hz (between the delta and the 
alpha power peak). Instead, the IAF was defined as the maximum power density peak between 
6 and 14 Hz. These frequency landmarks were originally introduced in the individual frequency 
analysis of EEG activity by Dr. Wolfgang Klimesch (Klimesch, 1996, 1999; Klimesch et al., 1998). 
The TF and IAF were computed for each subject involved in the study. Based on the TF 
and IAF, we estimated the individual delta, theta, and alpha bands as follows: delta from TF -
4 Hz to TF -2 Hz, theta from TF -2 Hz to TF, low-frequency alpha (alpha 1 and alpha 2) from TF 
to IAF, and high-frequency alpha (or alpha 3) from IAF to IAF + 2 Hz. In detail, the individual 
alpha 1 and alpha 2 bands were computed as follows: alpha 1 from TF to the frequency 
midpoint of the TF-IAF range and alpha 2 from that midpoint to IAF. The other bands were 
defined based on the standard fixed frequency ranges used in the reference study (Babiloni et 
al., 2017): beta 1 from 14 to 20 Hz, beta 2 from 20 to 30 Hz, and gamma from 30 to 40 Hz. Of 
note, the choice of  the division of alpha band into sub-bands was due to the fact that, in the 
eyes-closed rsEEG condition, dominant low-frequency alpha rhythms (alpha 1 and alpha 2) 
may denote the synchronization of diffuse neural networks regulating the fluctuation of the 
subject's global awake and conscious states, while high-frequency alpha rhythms (alpha 3) 
may denote the synchronization of more selective neural networks specialized in the 
processing of modal specific or semantic information (Klimesch, 1999; Pfurtscheller and Lopes 
da Silva, 1999). When the subject is engaged in sensorimotor or cognitive tasks, alpha and 
low-frequency beta (beta 1) rhythms reduce in power (i.e., desynchronization or blocking) and 
are replaced by fast EEG oscillations at high-frequency beta (beta 2) and gamma rhythms 
(Pfurtscheller and Lopes da Silva, 1999). 
Previous evidence showed that alpha power frequency-by-frequency might show a 
certain variability within the alpha band due to several physiological signals and instrumental 
noise (Nikulin at el., 2011). For this reason, we estimated the alpha-band variability (alpha 
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variability) based on the IAF and TF, and used it as a covariate in the main statistical analysis. 
Specifically, alpha variability was defined as the ratio between the alpha max and alpha 
extended. The alpha max was computed as the amplitude of cortical sources activity in the 
frequency range between IAF-1 and IAF+1 Hz, whereas the alpha extended was calculated as 
the amplitude of cortical source activity in the frequency ranges from TF to IAF-1 Hz and from 
IAF-1 to IAF+1 Hz. We used the freeware called exact LORETA (eLORETA) for the linear 
estimation of the cortical sources activity of rsEEG rhythms (for details see the reference study 
Babiloni et al., 2017). 
Statistical analysis was performed to evaluate the differences in the alpha variability in 
the following comparisons: MCI groups vs. Nold group (i.e., ADMCI and PDMCI ≠ Nold) and 
ADMCI group vs. PDMCI group (i.e., ADMCI  ≠  PDMCI). To this aim, we used an ANOVA with 
the alpha variability as a dependent variable (p < 0.05). The alpha variability values were 
preliminarily transformed using the log10 function to have a Gaussian distribution as revealed 
by Kolmogorov–Smirnov test (all log10 transformed alpha variability values presented a 
Gaussian distribution in the three groups, p > 0.05). The ANOVA factors were Group (Nold, 
ADMCI, and PDMCI) and ROI (frontal, central, parietal, occipital, and temporal). Duncan test 
was used for post-hoc comparisons (Bonferroni corrected p < 0.05). The results showed a 
significant interaction Group X ROI (F = 17.5, p = 0.00001). Duncan planned post-hoc (p < 
0.0033 to obtain the Bonferroni correction at p < 0.05) testing revealed that the discriminant 
LLC pattern ADMCI and PDMCI < Nold was fitted by the central (p <0.00001), parietal (p < 
0.000005), occipital (p < 0.000005), and temporal (p < 0.00005) sources. The discriminant 
pattern PDMCI < ADMCI was fitted by the same sources (p < 0.0002). The present results 
suggest that the alpha variability was different among Nold, ADMCI, and PDMCI. Therefore, 
we used the alpha variability as a covariate in the further statistical analysis on LLC solutions. 
 
Estimation of functional connectivity of rsEEG cortical sources  
The eLORETA freeware was used to estimate the “functional cortical connectivity” 
from rsEEG rhythms (Pascual-Marqui, 2007b). Specifically, we used the toolbox called lagged 
linear connectivity (LLC; Pascual-Marqui et al., 2011). LLC provides linear measurements 
(hereinafter LLC solutions) of the statistical interdependence of pairs of eLORETA cortical 
source activations estimated from scalp rsEEG rhythms at a given frequency. The procedure 
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provides LLC solutions between all combinations of voxels in the cortical source space of 
eLORETA (Pascual-Marqui et al., 2011). In its practical use, researchers can average those LLC 
solutions across eLORETA voxels for pairs of regions of interest (ROIs).  
Noteworthy, LLC solutions are estimated by removing the zero-lag instantaneous 
phase interactions between rsEEG cortical sources estimated by eLORETA freeware. The 
rationale is that these zero-lag phase interactions could be affected by instantaneous physical 
propagation of neural ionic currents from a given source to all the others merely due to head 
volume conductor effects (Pascual-Marqui, 2007b). Furthermore, the LLC solutions took into 
account measures of interdependence among multivariate rsEEG time series, thus partially 
mitigating the so-called “common drive/source” effect of a “third” source on the LLC solutions 
estimated between two sources of interest (Pascual-Marqui, 2007c). 
For each subject and frequency band of interest (i.e. delta, theta, alpha 1, alpha 2, alpha 
3, beta 1, beta 2, and gamma), LLC solutions were computed for 5 ROIs, namely frontal, 
central, parietal, occipital, and temporal lobes in the eLORETA cortical source space (Pascual-
Marqui, 2007a).  
For the interhemispheric analysis, the LLC solutions were calculated between all voxels 
of the mentioned ROIs of each hemisphere with the homologous ones of the other 
hemisphere. The LLC solutions for all voxels of a given pair of ROIs were averaged. For each 
frequency band of interest, the following 5 interhemispheric LLC solutions were computed: 
frontal (i.e. frontal left - frontal right LLC), central (i.e. central left - frontal central LLC), parietal 
(i.e. parietal left - parietal right LLC), occipital (i.e. occipital left - occipital LLC), and temporal 
(i.e. temporal left - temporal right LLC). 
For the intrahemispheric analysis, the LLC solutions were computed for all voxels of a 
particular ROI with all voxels of another ROI of the same hemisphere. The LLC solutions for all 
voxels of a given pair of ROIs were averaged. This operation was repeated for the left and the 
right hemisphere, separately. In particular, for each frequency band of interest and the left 
hemisphere, the following 5 left intrahemispheric LLC solutions were computed: (1) frontal 
(i.e., mean among left frontal - central, left frontal - parietal, left frontal - temporal, and left 
frontal - occipital LLC), (2) central (i.e., mean among left central - frontal, left central - parietal, 
left central - temporal, and left central - occipital LLC), (3) parietal (i.e., mean among left 
parietal - frontal, left parietal - central, left parietal - temporal, and left parietal - occipital LLC), 
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(4) occipital (i.e., mean among left occipital - frontal, left occipital - central, left occipital - 
parietal, and left occipital - temporal LLC), and (5) temporal (i.e., mean among left temporal - 
frontal, left temporal - central, left temporal - parietal , and left temporal - occipital LLC). The 
same procedure was repeated for the right hemisphere.   
Of note, the five ROIs (i.e., frontal, central, parietal, occipital, and temporal), even if 
bigger than that obtainable by anatomical oriented template like Automated Anatomical 
Labeling (Marino et al., 2016), may be acceptable when applied to the cortical source 
estimation of eyes-closed resting state EEG rhythms for at least three reasons: (1) the eyes-
closed rsEEG rhythms are widely represented across human cerebral cortex, in contrast to the 
circumscribed functional topography of event-related EEG changes (Babiloni et al., 2016a); (2) 
the spatial resolution of rsEEG recording with 19 scalp electrodes positioned according to the 
10–20 System is low; and (3) the spatial resolution of the eLORETA solutions is low for its 
peculiar maximally-smoothing regularization procedure (Pascual-Marqui, 2007b). 
 
Statistical analysis of the LLC of rsEEG cortical sources 
A statistical session was performed by the commercial tool STATISTICA 10 (StatSoft Inc., 
www.statsoft.com) to test the hypothesis that the “functional cortical connectivity” as A 
statistical session was performed by the commercial tool STATISTICA 10 (StatSoft Inc., 
www.statsoft.com) to test the hypothesis that the “functional cortical connectivity” of rsEEG 
rhythms as revealed by the eLORETA LLC between rsEEG source pairs (hereinafter LLC 
solutions) may be abnormal in the ADMCI and PDMCI groups compared to the Nold group. 
Furthermore, an exploratory statistical analysis tested possible different abnormalities 
between the ADMCI and PDMCI groups. In this sessions, two ANOVAs were computed using 
the eLORETA LLC solutions as a dependent variable (p < 0.05). LLC solutions were transformed 
using the log10 function to have a Gaussian distribution. Furthermore, alpha variability was 
used as a covariate. Mauchly's test evaluated the sphericity assumption. The degrees of 
freedom were corrected by the Greenhouse-Geisser procedure when appropriate (p < 0.05). 
More details on the two ANOVAs are reported as next. 
The first ANOVA tested the differences of interhemispheric LLC solutions between MCI 
groups vs. Nold group (i.e., ADMCI and PDMCI ≠ Nold) and ADMCI group vs. PDMCI group (i.e., 
ADMCI ≠  PDMCI). The ANOVA factors were Group (Nold, ADMCI, and PDMCI), Band (delta, 
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theta, alpha 1, alpha 2, alpha 3, beta 1, beta 2, and gamma), and ROI (frontal, central, parietal, 
occipital, and temporal).  
The second ANOVA tested the differences of intrahemispheric LLC solutions between 
MCI groups vs. Nold group (i.e., ADMCI and PDMCI ≠ Nold) and ADMCI group vs. PDMCI group 
(i.e., ADMCI ≠  PDMCI). The ANOVA factors were Group (Nold, ADMCI, and PDMCI), 
Hemisphere (left and right), Band (delta, theta, alpha 1, alpha 2, alpha 3, beta 1, beta 2, and 
gamma), and ROI (frontal, central, parietal, occipital, temporal, and limbic).   
In this statistical session, the confirmation of the primary hypothesis may require: (1) a 
statistically significant ANOVA effect including the factor Group (p < 0.05) and (2) a post-hoc 
Duncan test indicating statistically significant (p < 0.05, one-tailed, Bonferroni corrected) 
differences in the LLC solutions between MCI groups vs. Nold group (i.e., ADMCI and PDMCI > 
Nold in delta sources; ADMCI and PDMCI < Nold in alpha sources; p < 0.05, one-tailed, 
Bonferroni corrected). Concerning the exploratory analysis, a post-hoc Duncan test evaluated 
possible differences in the LLC solutions between the ADMCI vs. the PDMCI group (i.e., ADMCI 
≠ PDMCI; p > 0.05 two-tailed, Bonferroni corrected).  
The input data for the mentioned statistical analyses were controlled by the Grubbs test 
(p < 0.0001) for the presence of outliers in the distribution of the LLC solutions. 
As an exploratory statistical analysis at the individual level, Spearman test evaluated the 
correlation between the MMSE score and LLC solutions showing statistically significant 
differences between the Nold and the MCI groups (Bonferroni corrected p < 0.05). The 
correlation analysis was performed considering all Nold, ADMCI, and PDMCI individuals as a 
whole group for two reasons. On the one hand, the hypothesis was that LLC solutions from 
rsEEG cortical sources were correlated with the global cognitive status of seniors in general, 
namely including cases with both normal and impaired cognitive functions. On the other hand, 
the correlation study would have had a low statistical sensitivity if performed only in the 
separate groups, due to the very limited scatter of the MMSE scores within a given group (e.g., 
in Nold subjects, the MMSE score can just assume discrete values of 30, 29, and 28). To take 
into account the inflating effects of repetitive univariate tests, the statistical threshold was 
determined based on the Bonferroni correction at p < 0.05.  
 
Accuracy of the discrimination between the Nold, ADMCI, and PDMCI individuals  
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For minimizing the statistical analyses and false discoveries in the present study, 
eLORETA LLC solutions showing statistically significant ANOVA differences (p < 0.05) among 
the three groups (i.e. effects of the factor Group and Duncan post-hoc) were used as 
discriminant variables for the classification of the Nold subjects and the MCI subjects of each 
group (i.e. Nold vs. ADMCI and Nold vs. PDMCI). These classifications were performed by 
GraphPad Prism software (GraphPad Software, Inc, California, USA) using its implementation 
of ROC curves (DeLong et al., 1988). The following indexes measured the results of the binary 
classifications: (1) Sensitivity. It measures the rate of the cases (i.e. subjects with MCI in the 
classifications of those MCI and Nold subjects) who were correctly classified as cases (i.e. “true 
positive rate” in the signal detection theory); (2) Specificity. It measures the rate of the 
controls (i.e. Nold subjects in the classifications of those subjects and MCI subjects) who were 
correctly classified as controls (i.e. “true negative rate” in the signal detection theory); (3) 
Accuracy. It is the mean between the sensitivity and specificity weighted for the number of 
cases and controls; and (4) AUROC curve. For sake of brevity, the AUROC curve was used as a 
major reference index of the global classification accuracy. 
 
Results 
Comparison of eLORETA interhemispheric LLC solutions among Nold, ADMCI, and PDMCI 
groups 
Figure 1 shows mean values (± standard error mean, SE) of the interhemispheric LLC 
solutions for: three groups (Nold, ADMCI, and PDMCI), eight bands (delta, theta, alpha 1, alpha 
2, alpha 3, beta 1, beta 2, and gamma), and five ROIs (frontal, central, parietal, occipital, and 
temporal). Here the LLC solutions reflect the statistical interdependence of pairs of 
homologous eLORETA cortical sources between the two hemispheres, estimated from scalp 
rsEEG rhythms at the frequency bands of interest. In Figure 1, the profile and magnitude of 
the interhemispheric LLC solutions differed across the ROIs and frequency bands within and 
between the Nold, ADMCI, and PDMCI groups, thus exploiting spatial and frequency 
information contents of the methodological approach. 
In the Nold group as a physiological reference, dominant values of interhemispheric LLC 
solutions were observed in temporal (maximum), occipital, and parietal alpha 2 and alpha 3 
sources. Low values of interhemispheric LLC solutions were found in the widespread delta, 
16 
 
theta, and alpha 1 sources. The LLC solutions in beta 1, beta 2, and gamma sources were very 
low. Summarizing, the Nold group was characterized by a prominent interhemispheric 
functional connectivity between posterior cortical sources of moderate to high-frequency 
alpha rhythms. Compared with the Nold group, the two MCI groups (i.e., ADMCI and PDMCI) 
showed a similar spatial and frequency profile of interhemispheric LLC solutions but a lower 
magnitude. In both MCI groups, there was a substantial decrease of the interhemispheric LLC 
solutions in frontal, central, parietal, occipital, and temporal alpha 2 and alpha 3 sources. 
Remarkably, no sensible differences in LLC solutions can be observed between the two MCI 
groups. 
Log10 transformation was used to make Gaussian the distributions of interhemispheric 
eLORETA LLC solutions in Nold, ADMCI, and PDMCI subjects. Kolmogorov–Smirnov test 
confirmed that all log10 transformed interhemispheric LLC solutions presented a Gaussian 
distribution in the Nold, ADMCI, and PDMCI groups (p > 0.05). The ANOVA on log10 
transformed interhemispheric eLORETA LLC solutions showed a significant interaction Group 
X Band X ROI (F = 1.4, p = 0.03). Duncan planned post-hoc testing (p < 0.00041 to obtain the 
Bonferroni correction at p < 0.05) revealed that the discriminant LLC pattern ADMCI and 
PDMCI < Nold was fitted by the parietal (p < 0.00002), occipital (p < 0.00001), and temporal (p 
< 0.000005) alpha 2 sources as well as parietal (p < 0.00001), occipital (p < 0.00001), and 
temporal (p < 0.00001) alpha 3 sources. This interhemispheric effect well distinguished 
ADMCI/PDMCI and Nold at the group level. Of note, no differences (p > 0.05) in the 
interhemispheric LLC solutions were found between the two MCI groups (i.e., ADMCI and 
PDMCI). 
Insert here Figure 1 
 
 Comparison of eLORETA intrahemispheric LLC solutions among Nold, ADMCI, and PDMCI 
groups 
Figure 2 plots mean values (± SE) of the intrahemispheric LLC solutions for: three groups 
(Nold, ADMCI, and PDMCI), eight bands (delta, theta, alpha 1, alpha 2, alpha 3, beta 1, beta 2, 
and gamma), and five ROIs (frontal, central, parietal, occipital, and temporal). In Figure 2, the 
profile and magnitude of the intrahemispheric LLC solutions differed across the ROIs and 
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frequency bands within and between the Nold, ADMCI, and PDMCI groups, again exploiting 
spatial and frequency information contents of the methodological approach.  
In the Nold group as a reference, dominant values of intrahemispheric LLC solutions 
were observed in temporal (maximum), occipital, and parietal alpha 2 and 3 sources while 
moderate values were found in central and frontal alpha 2 and 3 sources. Low values 
interhemispheric LLC solutions were registered in delta, theta, and alpha 1 sources in all ROIs. 
As for the interhemispheric LCC solutions, the intrahemispheric LLC solutions in beta 1, beta 
2, and gamma sources were very low. As for the interhemispheric functional connectivity, the 
Nold group was characterized by a prominent intrahemispheric functional connectivity in 
widespread cortical sources of moderate to high-frequency alpha rhythms. 
As for the interhemispheric LLC solutions, the two MCI groups (i.e., ADMCI and PDMCI) 
showed a similar spatial and frequency profile of intrahemispheric LLC solutions but a lower 
magnitude benchmarked against the Nold group. There was a substantial decrease in the 
intrahemispheric LLC solutions in frontal, central, parietal, occipital, and temporal alpha 2 and 
3 sources. Remarkably, no differences were observed between the two MCI groups. 
Log10 transformation was used to make Gaussian the distributions of intrahemispheric 
eLORETA LLC solutions in Nold, ADMCI, and PDMCI subjects. Kolmogorov–Smirnov test 
confirmed that all log10 transformed interhemispheric LLC solutions presented a Gaussian 
distribution in the Nold, ADMCI, and PDMCI groups (p > 0.05). The ANOVA on log10 
transformed intrahemispheric eLORETA LLC solutions showed a significant interaction Group 
X Band (F = 2.6, p = 0.001) regardless the hemispheres (i.e., the substantial symmetry of the 
intrahemispheric LLC solutions in the left and the right side) and ROIs. Duncan planned post-
hoc testing (p < 0.0021 to obtain the Bonferroni correction at p < 0.05) showed that the 
discriminant LLC pattern ADMCI and PDMCI < Nold was fitted by the global alpha 2 (p < 
0.000005) and alpha 3 (p < 0.00002) sources. This intrahemispheric effect distinguished 
ADMCI/PDMCI and Nold at the group level. Again, no differences (p > 0.05) in the 
intrahemispheric LLC solutions were found between the two MCI groups (i.e., ADMCI and 
PDMCI). 
Insert here Figure 2 
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A control statistical analysis was performed to verify that the above discriminant LLC 
solutions were not merely due to some outliers. To this aim, the Grubbs' test (p < 0.0001) 
evaluated the presence of outliers in the data of the three groups (i.e., Nold, ADMCI, and 
PDMCI). The analysis was performed for the two discriminant alpha intrahemispheric LLC 
solutions (i.e., global alpha 2; global alpha 3) and the six discriminant alpha interhemispheric 
LLC solutions (i.e., parietal, occipital, and temporal alpha 2; parietal, occipital, and temporal 
alpha 3). No outlier was found in any group (see Figure 3), thus confirming the results of the 
main statistical analysis. 
Insert here Figure 3  
 
Correlation of LLC solutions and MMSE scores across Nold, ADMCI, and PDMCI individuals  
As a first exploratory analysis at the individual level, Spearman test evaluated the 
correlation between the MMSE score, as a rough index of global cognition, and 8 LLC solutions 
(log10 transformed) showing statistically significant differences between the Nold and the 
MCI groups (p < 0.05). These LLC solutions are listed in the following: interhemispheric LLC 
solutions in parietal, occipital, and temporal alpha 2 and 3 sources; intrahemispheric LLC 
solutions in global alpha 2 and 3 sources.  
A statistically significant (p < 0.00625 to obtain the Bonferroni correction at p < 0.05) 
positive correlation was found between: (1) the interhemispheric LLC solutions in temporal 
alpha 2 (r = 0.19, p < 0.004), occipital alpha 3 sources (r = 0.21, p < 0.002), and the MMSE 
scores; (2) the intrahemispheric LLC solutions in global alpha 3 and the MMSE scores (r = 0.2, 
p < 0.003). The higher the LLC solutions, the higher the MMSE score. Figure 4 shows the 
scatterplots of those 3 LLC solutions showing statistically significant correlations (p < 0.05 
corrected). It was noted the large variability in the alpha source connectivity even within the 
Nold group and the relatively low values of the correlation coefficients. 
As a control analysis, the same correlation test was performed for any single group 
considered separately. No statistically significant result (p > 0.05) was observed, possibly due 
to the very limited range of the MMSE score within the single groups. 
Insert here Figure 4 
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Classification among Nold, ADMCI, and PDMCI individuals based on the discriminant LLC 
solutions  
As a second exploratory analysis at the individual level, the above eight LLC solutions 
(log10 transformed) showing statistically significant differences between the Nold and the 
MCI groups (p < 0.05) were used as an input to the computation of the AUROC curves. This 
computation tested the ability of those LLC solutions in the classification of Nold subjects vs. 
MCI (i.e., ADMCI and PDMCI) subjects.  
Results of the classification between Nold vs. ADMCI individuals showed that only the 
interhemispheric LLC solutions in the temporal alpha 3 sources overcome the threshold of 0.7 
of the AUROC curve, defined as a “moderate” classification rate. The interhemispheric LLC 
solutions in the temporal alpha 3 sources reached the following classification rate (Figure 5 
top): a sensitivity of 73%, a specificity of 64%, an accuracy of 68.5%, and an AUROC curve of 
0.71.  
Concerning the classification of the Nold vs. PDMCI individuals, only the 
interhemispheric LLC solutions in the temporal alpha 2 sources overcome the threshold of 0.7 
of the AUROC curve. The interhemispheric LLC solutions in the temporal alpha 2 sources 
reached the following classification rate (Figure 5 bottom): a sensitivity of 66.7%, a specificity 
of 69.3%, an accuracy of 68%, and an AUROC curve of 0.72.  
Furthermore, no substantial classification accuracy between the ADMCI and PDMCI 
individuals was revealed at all. 
Insert here Figure 6  
 
Control analyses 
In the main data analysis, alpha rhythms were divided in sub-bands based on clinical 
standards (International Federation of Clinical Neurophysiology Guidelines of Nuwer et al. 
1999 and Guidelines of the International Pharmaco-EEG Society of Jobert et al. 2012) as well 
as previous neurophysiological evidence showing that dominant low- (alpha 1 and alpha 2) 
and high-frequency (alpha 3) alpha rhythms may have a different weight in the fluctuation of 
vigilance and processing of modal specific, sensorimotor or semantic information, respectively 
(Klimesch, 1999; Pfurtscheller and Lopes da Silva, 1999). However, it has been suggested that 
alpha rhythms may have global features as a whole band (International Federation of Clinical 
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Neurophysiology Glossary of Nuwer et al. 1999 and Guidelines of the International Pharmaco-
EEG Society of Kane et al., 2017). Therefore, we performed a control analysis to evaluate the 
differences of LLC solutions in the whole alpha band between MCI groups vs. Nold group (i.e., 
ADMCI and PDMCI ≠ Nold) and ADMCI group vs. PDMCI group (i.e., ADMCI ≠ PDMCI). We 
addressed this issue using the TF and IAF as landmarks. Firstly, the individual whole alpha band 
was defined as the frequency range  from TF to IAF + 2 Hz. Secondly, we computed the 
interhemispheric and intrahemispheric LLC solutions in the individual whole alpha band. 
Figure 6 showed the mean values (± SE) of the interhemispheric (left) and intrahemispheric 
(right) LLC of eLORETA rsEEG cortical sources in whole alpha band for: three groups (Nold, 
ADMCI, and PDMCI) and five ROIs (frontal, central, parietal, occipital, and temporal). 
Compared with the Nold group, the two MCI groups (i.e., ADMCI and PDMCI) showed a 
substantial decrease of the posterior interhemispheric and widespread alpha 
intrahemispheric LLC solutions. Thirdly, we performed two ANOVAs using the eLORETA LLC 
solutions in the whole alpha band as a dependent variable (p < 0.05). LLC solutions were 
transformed using the log10 function to have a Gaussian distribution as revealed by 
Kolmogorov–Smirnov test (all log10 transformed LLC solutions presented a Gaussian 
distribution in the three groups, p > 0.05). Alpha variability was used as a covariate.  
The first control ANOVA was focused on the differences of interhemispheric LLC 
solutions in the whole alpha band among Nold, ADMCI, and PDMCI. The ANOVA factors were 
Group (Nold, ADMCI, and PDMCI) and ROI (frontal, central, parietal, occipital, and temporal). 
Instead, the second control ANOVA was focused on the differences of intrahemispheric LLC 
among Nold, ADMCI, and PDMCI. The ANOVA factors were Group (Nold, ADMCI, and PDMCI), 
Hemisphere (left and right), and ROI (frontal, central, parietal, occipital, temporal, and limbic). 
Duncan test was used for post-hoc comparisons (Bonferroni corrected p < 0.05). Specifically, 
we tested the following prediction: (1) a statistically significant effect including the factor 
Group (p < 0.05) and (2) a post-hoc test indicating statistically significant differences in the 
alpha LLC solutions between MCI groups vs. Nold group (i.e., ADMCI, PDMCI ≠ Nold; p < 0.05 
one-tailed). As an exploratory analysis, a post-hoc test tested possible significant differences 
in the alpha LLC solutions between ADMCI group vs. PDMCI group (i.e., ADMCI ≠ PDMCI; p < 
0.05 two-tailed).  
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The results of the first ANOVA showed a significant interaction Group X ROI (F = 2.5, p = 
0.01). Duncan planned post-hoc (p < 0.0033 to obtain the Bonferroni correction at p < 0.05) 
testing revealed that the discriminant LLC pattern ADMCI and PDMCI < Nold was fitted by the 
parietal (p < 0.001), occipital (p < 0.00005), and temporal (p < 0.0001) alpha sources. This 
interhemispheric effect distinguished ADMCI/PDMCI and Nold at the group level. No 
differences (p > 0.05) in the alpha interhemispheric LLC solutions were found between the 
two MCI groups (i.e., ADMCI and PDMCI).  
Similarly, the results of the second ANOVA showed a significant interaction Group X ROI 
(F = 2.9, p = 0.003). Duncan planned post-hoc testing (p < 0.0033 to obtain the Bonferroni 
correction at p < 0.05) revealed that the discriminant LLC pattern ADMCI and PDMCI < Nold 
was fitted by the central (p < 0.002), parietal (p <0.00003), occipital (p < 0.00003), and 
temporal (p < 0.0001) alpha sources. This intrahemispheric effect distinguished ADMCI/PDMCI 
and Nold at the group level. Again, no differences (p > 0.05) in the alpha intrahemispheric LLC 
solutions were found between the two MCI groups (i.e., ADMCI and PDMCI).  
The present results of this control analysis suggest that the interhemispheric and 
intrahemispheric LLC solutions in whole alpha sources were abnormally lower in both MCI 
groups compared to the Nold group. These results also suggest that there is a global alteration 
of alpha rhythms in ADMCI and PDMCI patients set in resting state eyes-closed condition.  
Insert here Figure 6  
A second control analysis was performed to evaluate the differences of alpha 
intrahemispheric LLC solutions between MCI groups vs. Nold group (i.e., ADMCI and PDMCI ≠ 
Nold) and ADMCI group vs. PDMCI group (i.e., ADMCI  ≠  PDMCI) using a higher number of 
cortical source pairs in line with a previous study of our group in Nold subjects and AD patients 
with dementia (Babiloni et al., 2016b). We considered the following cortical source pairs for 
the alpha 2 and alpha 3 bands and both hemispheres: frontal-central, frontal-temporal, 
central-temporal, frontal-parietal, central-parietal, temporal-parietal, frontal-occipital, 
central-occipital, temporal-occipital, and parietal-occipital. For those source pairs, the 
eLORETA LLC solutions were used as a dependent variable in an ANOVA design (p < 0.05). LLC 
solutions were preliminarily transformed using the log10 function to ensure a Gaussian 
distribution in all cases. Alpha variability was used as a covariate. The ANOVA factors were 
Group (Nold, ADMCI, and PDMCI), Hemisphere (left and right), Band (alpha 2 and alpha 3), 
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and Pair of ROIs (frontal-central, frontal-temporal, central-temporal, frontal-parietal, central-
parietal, temporal-parietal, frontal-occipital, central-occipital, temporal-occipital, and 
parietal-occipital). Duncan test was used for post-hoc comparisons (Bonferroni corrected p < 
0.05). Specifically, we tested the following predictions: (1) a statistically significant effect 
including the factor Group (p < 0.05) and (2) a post-hoc test indicating statistically significant 
differences in the alpha intrahemispheric LLC solutions between MCI groups vs. Nold group 
(i.e., ADMCI, PDMCI ≠ Nold; p < 0.05 one-tailed). As an exploratory analysis, we tested possible 
differences in the alpha interhemispheric LLC solutions between ADMCI group vs. PDMCI 
group (i.e., ADMCI ≠ PDMCI; p < 0.05 two-tailed).  
The results showed a significant interaction Group X Pair of ROIs (F = 3.1, p = 0.00001), 
regardless the hemispheres and alpha sub-bands. Duncan planned post-hoc testing (p < 
0.0016 to obtain the Bonferroni correction at p < 0.05) revealed that the discriminant LLC 
pattern ADMCI and PDMCI < Nold was fitted by the temporal-parietal (p < 0.0001), central-
occipital (p <0.0004), temporal-parietal (p < 0.001), and parietal-occipital (p < 0.000005) alpha 
sources. No differences in the alpha intrahemispheric LLC solutions were found between the 
two MCI groups (i.e., ADMCI and PDMCI). These results suggest that both MCI groups 
exhibited abnormally lower intrahemispheric LLC solutions in temporal-parietal, central-
occipital, temporal-parietal, and parietal-occipital alpha sources. Figure 7 reports the mean 
values (± SE) of the intrahemispheric LLC of eLORETA rsEEG cortical sources for three groups 
(Nold, ADMCI, and PDMCI), two alpha sub-bands (alpha 2 and alpha 3), and ten pairs of ROI 
(frontal-central, frontal-temporal, central-temporal, frontal-parietal, central-parietal, 
temporal-parietal, frontal-occipital, central-occipital, temporal-occipital, and parietal-
occipital). 
Insert here Figure 7  
An advanced and systematic classification of Nold, ADMCI, and PDMCI individuals on 
the basis of rsEEG source connectivity markers was beyond the aims of the present study. 
However, it may be argued that the lack of significant classifications between the ADMCI and 
PDMCI individuals was due to a sub-optimal procedure, namely we used single features of 
rsEEG source connectivity, selected with statistical criteria, as inputs to ROC curve. This sub-
optimal procedure may not use all useful information content available in the LLC solutions. 
To address this issue, we performed  a control analysis aimed at testing the hypothesis that 
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the present LLC solutions were not able to discriminate between the ADMCI and PDMCI 
individuals even using an advanced methodology of classification. For this control analysis, a 
standard support vector machine (SVM, Cristianini and Shawe-Taylor, 2000), implemented in 
MATLAB and Statistics Toolbox (Release 2015a; The MathWorks, Inc., Natick, Massachusetts, 
United States.), was used as a mathematical classifier. One-hundred runs of classifications 
were performed, and the classification results were averaged across these runs to estimate 
mean sensitivity, specificity, and accuracy in the discrimination between the ADMCI and 
PDMCI individuals. The whole procedure was realized by a MATLAB script. 
The application of the MATLAB script to the real LLC solutions was performed in four 
procedural steps, which constituted a single run. 
In the first step, the two patients’ groups (i.e., ADMCI and PDMCI) were randomly 
subdivided into three parts: 40% of the ADMCI and PDMCI individuals were selected for the 
feature extraction from LLC solutions (featuring set), 40% of them served for the training of 
the SVM (training set), and the remaining 20% of them were utilized for the testing phase of 
the classifier (testing set). 
In the second step, a standard principal component analysis (PCA), implemented in the 
mentioned MATLAB and Statistics Toolbox, extracted the features from practically all relevant 
LLC variables of the featuring set (40% of the ADMCI and PDMCI individuals). Namely, we 
considered 3 frequency bands (i.e., delta, theta, and the mean between alpha 2 and alpha 3) 
X 10 source pairs as described in the Methods (intrahemispheric and interhemispheric LLC 
solutions in frontal, central, parietal, occipital, and temporal source pairs). In total, 30 LLC 
variables were considered for any MCI individual dataset. No selection based on statistical 
considerations was made to avoid the overfitting. The PCA provided 30 principal components 
(PCs) corresponding to the 30 input LLC variables. Each PC was a linear combination of the 
original LLC variables (minus their mean value) weighted using a set of coefficients called 
loadings and can be considered as a coordinate in a “multidimensional space.” The 30 PCs 
were sorted in descending order based on the variance explained in the LLC variables. Starting 
from the first PC (i.e., the one responsible of the greatest percentage of the variance), a given 
number (“n”) of PCs explained at least 80% of the total variance in the LLC variables. Let us 
consider an example in which “n” is equal to four (e.g., the first PC explaining 40% of the 
variance, the second PC explaining 25% of the variance, the third PC explaining 10% of the 
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variance, and the fourth PC explaining 6% of the variance = 81%). In this example, the four PCs 
can be considered as four new variables (i.e., four coordinates in the new “multidimensional 
space”), each formed by 60 values (one for any MCI individual of the featuring set). 
In the third step, the loadings derived from the second step were used to transform the 
training set using the same linear combination of the featuring set, namely projecting the 30 
LLC variables of the training set (40% of the ADMCI and PDMCI individuals) into the same 
“multidimensional space” of the featuring set. According to the example of step 2, 30 new 
transformed variables (“extracted features”) were computed (one for any LLC variable), each 
formed by 60 values (one for any MCI individual in the training set). However, only the first 4 
transformed variables (corresponding to the first four PCs of step 2) were used as an input for 
the training of the SVM in the discrimination between ADMCI and PDMCI individuals. The 
trained SVM was used in the following step.  
In the fourth step, the loadings derived from the second step were also used to 
transform the testing set using the same linear combination of the featuring set, namely 
projecting the 30 LLC variables of the testing set (remaining 20% of the ADMCI and PDMCI 
individuals) into the same “multidimensional space” of the featuring set. Each of the 30 new 
transformed variables (one for any LLC variable) was formed by 30 values (one for any MCI 
individual in the testing set). According to the example of step 2, only the first 4 transformed 
variables (corresponding to the four PCs of step 2) were used as an input for testing the trained 
SVM in the discrimination between ADMCI and PDMCI individuals. The outcome of the trained 
SVM was reported as sensitivity, specificity, and accuracy.  
The above step-wise procedure provided the following results as an average of the 100 
runs: (1) the mean “n” was 4.31 ± 0.26 SE; (2) the training of the SVM showed a sensitivity of 
77.41% ± 5.01% SE, a specificity of 49.55% ± 9.12% SE, and an accuracy of 63.48% ± 7.06% SE; 
(3) the testing of the trained SVM exhibited a sensitivity of 62.32% ± 2.51% SE, a specificity of 
37.62% ± 3.22% SE, and an accuracy of 49.97% ± 2.86% SE. These results confirmed those of 
the main analysis, namely the LLC solutions estimated in the present study were not able to 
discriminate between the ADMCI and PDMCI individuals, possibly reflecting common 
abnormalities in the underlying neurophysiological mechanisms of the two diseases.  
As a methodological remark, the MATLAB script was preliminarily validated by a 
simulation study in random datasets generated by a computerized procedure to mimic the 
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real 30 LLC variables for the 75 ADMCI and 75 PDMCI individuals of the present investigation. 
One dataset corresponded to 30 virtual LLC variables for any virtual MCI individual. For 
classification purposes, the above step-wise procedure (i.e., four steps) was used. Of note, this 
procedure was repeated for six sessions. In each session, the random datasets for the virtual 
ADMCI and PDMCI individuals were generated imposing pre-determined mean differences 
between groups in the simulated LLC variables (namely, 0%, 10%, 20%, 30%, 40%, 50%). The 
criterion of validation was the prediction that the classification procedure by the trained SVM 
may provide a classification accuracy between virtual ADMCI and PDMCI individuals increasing 
proportionally to the mentioned mean differences (i.e., from 0% to 50%).  This prediction was 
confirmed by the results of the simulation study. 
 
Discussion 
The present exploratory investigation tested the hypothesis that the rsEEG cortical 
source connectivity (i.e., LLC solutions) may be abnormal in ADMCI and PDMCI patients. In the 
following sections, the present results will be discussed to emphasize that such connectivity 
may provide no redundant neurophysiological information about the prodromal stages of the 
two neurodegenerative diseases compared with rsEEG cortical source activity estimated in 
the same ADMCI and PDMCI patients in a previous reference study (Babiloni et al., 2017).  
 
The “functional cortical connectivity” in alpha sources was abnormal in both ADMCI and 
PDMCI groups  
An interesting finding of the present study is that posterior interhemispheric and 
widespread intrahemispheric LLC solutions alpha sources were lower in both ADMCI and 
PDMCI groups as compared to the Nold subjects. No differences in the alpha LLC solutions 
were found between the two MCI groups. This finding, obtained with individual frequency 
alpha sub-bands, extends previous EEG evidence showing differences in the rsEEG cortical 
connectivity in ADD and PDD groups benchmarked against Nold subjects (Adler et al., 2003; 
Andersson et al., 2008; Anghinah et al., 2000; Besthorn et al., 1994b; van Dellen et al., 2015; 
Dunkin et al., 1994; Fonseca et al., 2013, 2011, Jelic et al., 2000, 1997; Knott et al., 2000; 
Leuchter et al., 1992, 1987; Locatelli et al., 1998; Moazami-Goudarzi et al., 2008; Pogarell et 
al., 2005; Sloan et al., 1994). In those previous studies using fixed rsEEG frequency bands, ADD 
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patients were characterized by a lower “functional cortical connectivity” estimated by the 
between-electrode pair coherence in alpha and beta rhythms, with a dominant abnormality 
in the dominant anterior-posterior axis (Adler et al., 2003; Anghinah et al., 2000; Babiloni et 
al., 2004, 2006a; Besthorn et al., 1994b; Blinowska et al., 2017; Dunkin et al., 1994; Fonseca 
et al., 2013, 2011, Jelic et al., 2000, 1997; Knott et al., 2000; Leuchter et al., 1992, 1987; 
Locatelli et al., 1998; Pogarell et al., 2005; Sloan et al., 1994). Similarly, previous investigations 
using fixed rsEEG frequency bands reported abnormalities in the intrahemispheric and 
interhemispheric anteroposterior alpha coherences in PD patients with cognitive deficits 
(Fonseca et al., 2013; Teramoto et al., 2016) and those with dementia with Lewy bodies 
(Dauwan et al., 2016). For the first time, the present finding unveiled that the abnormality in 
the alpha source connectivity can be observed even at the pre-dementia stage of AD and PD 
characterized by the MCI status, with no difference between the two patients’ groups.  
 
The “functional cortical connectivity” in alpha sources classified Nold vs. ADMCI and PDMCI 
individuals 
Here we report the results of two exploratory analyses aimed at testing the clinical 
relevance of the present findings. The first analysis showed a significant positive correlation 
between MMSE scores (roughly reflecting global cognitive status) and interhemispheric LLC 
solutions in temporal alpha 2 and occipital alpha 3 sources as well as the intrahemispheric LLC 
solutions in global alpha 3 sources across all Nold, ADMCI, and PDMCI individuals as a whole 
group. However, even if statistically significant (p < 0.005), the correlation values were 
relatively low as variance explained (i.e., r = 0.19–0.21). Furthermore, no statistically 
significant correlation (p > 0.05) was observed for any single group considered separately. The 
present findings suggest that neurophysiological mechanisms of the interdependence of 
cortical neural synchronization/desynchronization underpinning brain arousal and low 
vigilance (as reflected in the LLC solutions of this study) are only one of the determinants of 
global cognitive functions in human subjects. Other relevant neurophysiological mechanisms 
involved in cognitive information processes may be those related to selective attention, 
encoding and retrieval of information in long-term memory, frontal executive functions (some 
assisted by internal language), and others. Therefore, future studies may measure functional 
connectivity not only during the resting state condition (i.e., low vigilance) but also during 
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attention, episodic and working memory, and other cognitive tasks. The derived EEG markers 
may be used as a multivariate input for linear (logistics regression) and non-linear (artificial 
neural networks or support vector machines) predictors of the MMSE score in Nold subjects 
and patients with neurodegenerative disorders. The expected results may show high 
correlation values and remarkable insights about the derangement of brain functions in the 
evolution of neurodegenerative disorders. 
The second analysis showed a moderate classification accuracy of ADMCI and Nold 
individuals using the interhemispheric LLC solutions in the temporal alpha 3 sources (i.e., 
AUROC curve of 0.71). Finally, a moderate classification accuracy was obtained in PDMCI vs. 
Nold individuals using interhemispheric LLC solutions in temporal alpha 2 sources (i.e., the 
AUROC curve of 0.72). Noteworthy, those LLC solutions were not able to discriminate ADMCI 
vs. PDMCI individuals. 
Those findings about the individual level are in line with previous evidence showing the 
following values of classification accuracy of Nold and AD individuals: (1) 1.0–0.45 for Nold vs. 
ADD individuals (e.g. 1 = 100%); (2) 0.92–0.78 for MCI vs. ADD individuals; and (3) 0.87–0.60 
for the conversion from MCI to ADD status (Adler et al., 2003; Babiloni et al., 2016b; Bennys 
et al., 2001; Blinowska et al., 2017; Brassen et al., 2004; Buscema et al., 2007; Claus et al., 
1999; Engedal et al., 2015; Garn et al., 2017; Huang et al., 2000; Jelic et al., 2000; Knyazev et 
al., 2011; Lizio et al., 2015; Missonnier et al., 2006; Nuwer, 1997).  
Concerning the classification of Nold vs. PDMCI individuals, the present discrimination 
with 0.72 of success was lower than that reported in two studies using many discriminant 
rsEEG power density and connectivity measurements, namely 0.80-1.0 between PDD/DLB 
(dementia status) and Nold individuals (Engedal et al., 2015; Garn et al., 2017; Snaedal et al., 
2012). A straightforward explanation is that the previous studies obtained a better 
classification accuracy as the patients suffered from a manifest dementia rather than the MCI. 
To our knowledge, no previous cross-validated comparisons showed a high ability of rsEEG 
markers in the discrimination of ADMCI vs. PDMCI patients. 
 
The “functional cortical connectivity” in delta sources was normal in both ADMCI and PDMCI 
groups  
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Here we also report the negligible magnitude of the interhemispheric and 
intrahemispheric LLC solutions in delta sources estimated in the present Nold, ADMCI, and 
PDMCI groups. The fact that the delta source connectivity was normal in the PDMCI and the 
ADMCI group was surprising in the light of the following pieces of preceding evidence. It was 
documented that LLC solutions in delta sources were higher in ADD than Nold subjects 
(Babiloni et al., 2016b). Furthermore, there were differences between Nold and ADD 
individuals in functional connectivity measurements derived from delta rhythms recorded at 
scalp sensors (Adler et al., 2003; Blinowska et al., 2017; Knott et al., 2000; Locatelli et al., 1998; 
Sankari et al., 2011). Moreover, delta coherence between electrode pairs showed higher 
values in PDD compared with ADD patients (Fonseca et al., 2013).  
At the present early stage of the research, we cannot provide a final explanation about 
those contrasting results. At least in part, those discrepancies might be due to the present 
focus on the pre-dementia rather than the dementia stage of the AD and PD. Furthermore, to 
date, a clear cut distinction between MCI patients due to Lewy bodies, PD, and AD is not 
available even if biomarkers and fine clinical and neuropsychological testing reduced 
misdiagnosis (Albert et al., 2011; Dubois et al., 2014; McKeith et al., 2017). Therefore, some 
inhomogeneity in the different impact of mixed neurodegenerative disorders in the different 
studies cannot be excluded. Future studies should address these issues systematically in the 
same database to clarify the matter.  
 
The clinical neurophysiological model 
On the whole, the present markers of “functional cortical connectivity” in alpha sources 
lead support to the concept that AD and PD patients may share a similar clinical 
neurophysiological mechanism contributing to a “cortical disconnection syndrome” (Bokde et 
al., 2009; Teipel et al., 2016), even at the pre-dementia stage of the MCI status.  
 Noteworthy, the present markers of the “functional cortical connectivity” in alpha 
sources were not able to differentiate the PDMCI and ADMCI patients. This finding suggests 
that cholinergic ascending systems, which are impaired in both ADMCI and PDMCI groups 
(Bohnen et al., 2015), might play a significant role in the modulation of the “functional cortical 
connectivity”. This “cholinergic hypothesis” is based on a bulk of previous pharmaco-rsEEG 
evidence. In healthy adults, a single dose of a muscarinic cholinergic antagonist (i.e., 
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scopolamine) over placebo transiently increased resting state delta and theta power density 
while it reduced the power density at alpha and beta rhythms (Ebert and Kirch, 1998; Liem-
Moolenaar et al., 2011). A similar effect was also observed in Nold and ADD patients as a 
function of the integrity of cholinergic neurotransmission (Neufeld et al., 1994). Finally, a 
single dose of scopolamine deranged composite measurements of power density and 
coherence from delta to gamma in ADD patients kept in resting state condition (Johannsson 
et al., 2015; Snaedal et al., 2010).  
Concerning the above speculation, less clear is the previous evidence about the effects 
of Acetylcholinesterase inhibitor drugs (i.e., enhancing the cholinergic tone) in ADD patients. 
Some studies reported a beneficial increase or a less reduction of alpha rhythms over time in 
ADD patients in line with the present “cholinergic” hypothesis (Agnoli et al., 1983; Babiloni et 
al., 2006b; Balkan et al., 2003). Furthermore, there was an increment in the alpha-theta ratio 
observed after a single dose of an Acetylcholinesterase inhibitor drug administered to ADD 
patients clinically responding to a long chronic treatment when compared to the non-
responders (Alhainen et al., 1991). However, this effect might be not specific as a beneficial 
effect of the cholinergic treatment in ADD patients was also observed as decreased delta 
(Adler and Brassen, 2001; Balkan et al., 2003; Gianotti et al., 2008; Reeves et al., 2002) and 
theta (Adler et al., 2004; Brassen and Adler, 2003; Gianotti et al., 2008) rhythms. 
Future well-controlled pharmacological experiments are needed to have a direct 
measure of the correlation between alpha source functional connectivity and cholinergic 
transmission. 
 
Methodological remarks 
In the reference study carried out in the same Nold, ADMCI, and PDMCI populations 
(Babiloni et al., 2017), we discussed some methodological limitations of this retrospective and 
explorative study. Summarizing, these limitations include the relatively small number of the 
patients (N = 75) and the lack of (1) unified experimental recording protocol across the Clinical 
units involved, (2) harmonized hardware for EEG recordings and neuroimaging, (3) extensive 
neuroimaging (e.g., systematic use of Dopamine Transporter Scan, DAT-scan, in all patients), 
(4) extensive neuropsychological battery (e.g., Alzheimer's Disease Assessment Scale-
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cognitive subscale, ADAS-Cog) in all clinical Units, and (5) repeated clinical exams and 
instrumental recordings over time.  
Here an additional methodological limitation is discussed. In the present study, 19 scalp 
electrodes (e.g., 10–20 system) were used for EEG recordings as a clinical standard in all Units 
of this international Consortium. Noteworthy, 10–20 system is not ideal for an optimal spatial 
sampling of EEG and source analysis (Liu et al., 2002; Marino et al., 2016). Rather, an optimal 
EEG recording may use 64-128 electrodes. However, 19 electrodes may be still acceptable as 
a minimum number of sensors for a cortical source estimation of eyes-closed rsEEG rhythms 
in patients with neurodegenerative disorders. Indeed, these rhythms are assumed to reflect a 
state of mental and muscular relaxation possibly associated with a diffuse cortical neural 
synchronization at alpha frequencies and, in those patients, a diffuse abnormal cortical neural 
synchronization at delta frequencies (Babiloni et al., 2016a, 2016b, 2017). This distributed 
pattern of cortical neural synchronization may not require mandatorily the high spatial 
sampling of EEG activity and fine-grain source analysis necessary to study the circumscribed 
functional topography of evoked- or event-related potentials (Babiloni et al., 2016a). Indeed, 
rsEEG rhythms may represent the summation at scalp electrodes of the oscillatory component 
of post-synaptic potentials generated in large masses of cortical pyramidal neurons (several 
squared centimetres; Nunez and Srinivasan, 2006; Srinivasan et al., 2007) as sources of 
electromagnetic fields. However, we are aware of the importance that future studies will 
perform rsEEG recordings with 64-128 electrodes to enhance the spatial resolution of source 
estimation and connectivity. 
 
Conclusions 
A previous reference investigation showed robust abnormalities in cortical sources of 
delta and alpha rhythms, as markers of brain neural “synchronization/desynchronization,” in 
ADMCI and PDMCI patients set in the resting state condition compared to Nold subjects 
(Babiloni et al., 2017). Furthermore, there were some slight differences in those rhythms even 
between the ADMCI and PDMCI groups. Here we re-analyzed those original rsEEG data with 
the primary hypothesis that LLC solutions between cortical sources, as markers of “functional 
cortical connectivity,” may be abnormal in ADMCI and PDMCI patients compared with Nold 
subjects. The analysis was performed at the individual and the group level. Noteworthy, we 
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expected that such connectivity might provide no redundant neurophysiological information 
about the prodromal stages of the two neurodegenerative diseases compared with rsEEG 
cortical source activity estimated in the reference investigation (Babiloni et al., 2017).  
At the group level, the findings showed that posterior interhemispheric and 
intrahemispheric connectivity (i.e., LLC solutions) in alpha sources was abnormally lower in 
both ADMCI and PDMCI groups when compared to the Nold group. Instead, no difference in 
those markers was found between the two MCI groups. 
At the individual level, AUROC curves of LLC solutions in temporal alpha sources 
exhibited moderate accuracies in the classification of the Nold vs. ADMCI individuals (0.71) 
and the Nold vs. PDMCI individuals (0.72). Again, LLC solutions were not successful in the 
classification of the ADMCI vs. PDMCI individuals. 
In contrast to previous evidence based on rsEEG cortical source activity (Babiloni et al., 
2017), the findings of this study suggest similar abnormalities in widespread alpha (but not 
delta) source connectivity in ADMCI and PDMCI patients. This finding may reflect a common 
cholinergic impairment in those prodromal stages of AD and PD.  
On the whole, the results of the previous reference study (Babiloni et al., 2017) and the 
present investigation provide a clear evidence of the complementary and no redundant 
information of “synchronization/desynchronization” and “connectivity” markers that can be 
derived by non-invasive and cost-effective techniques applied on rsEEG rhythms in ADMCI and 
PDMCI patients. 
However, some methodological limitations in this retrospective investigation (e.g., lack 
of harmonized experimental procedures in the participant clinical units) motivate future 
studies for a cross-validation of the present findings. Ideally, prospective longitudinal studies 
may record rsEEG data from 32-64 scalp electrodes in de-novo ADMCI and PDMCI patients for 
the extraction of the present “connectivity” markers before and after six months of treatment 
with Acetylcholinesterase inhibitors. These markers may be obtained with more than one 
procedure (i.e., LLC, isolated effective coherence, etc.; Pascua-Marqui et al., 2011, 2014), and 
results of these procedures may be compared within and between groups for confirmatory 
purposes. An important criterion to select the best procedure for rsEEG source connectivity 
analysis may be the ability to reduce the large variability in the alpha source connectivity in 
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both Nold and MCI subjects and enhance the correlation coefficients with clinically relevant 
variables. 
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Table legends 
Table 1. Mean values (± standard error mean, SE) of the demographic and clinical data and 
results of their statistical comparisons (p < 0.05) in the groups of normal elderly (Nold) subjects 
and patients with mild cognitive impairment due to Alzheimer’s (ADMCI) and Parkinson’s 
(PDMCI) diseases. Legend: MMSE = Mini Mental State Evaluation; M/F = males/females; n.s. 
= not significant (p > 0.05). 
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Figure legends 
Figure 1. Mean values (± SE) of the interhemispheric lagged linear connectivity (LLC) of 
eLORETA resting state electroencephalographic (rsEEG) cortical sources for three groups 
(Nold, ADMCI, PDMCI), eight bands (delta, theta, alpha 1, alpha 2, alpha 3, beta 1, beta 2, 
gamma), and five ROIs (frontal, central, parietal, occipital, temporal).  
 
Figure 2. Mean values (± SE) of the intrahemispheric lagged linear connectivity (LLC) of 
eLORETA rsEEG cortical sources for three groups (Nold, ADMCI, PDMCI), eight bands (delta, 
theta, alpha 1, alpha 2, alpha 3, beta 1, beta 2, gamma), and five ROIs (frontal, central, parietal, 
occipital, temporal).  
 
Figure 3. Individual values of the interhemispheric and intrahemispheric LLC (log10 
transformed) of eLORETA rsEEG cortical sources showing statistically significant (p<0.05) 
differences among the Nold, ADMCI, and PDMCI groups (i.e., interhemispheric parietal, 
occipital, and temporal alpha 2; interhemispheric parietal, occipital, and temporal alpha 3; 
intrahemispheric global alpha 2; intrahemispheric global alpha 3). Noteworthy, the Grubbs' 
test showed no outliers from those individual values of the LLC of eLORETA rsEEG cortical 
sources (arbitrary threshold of p < 0.0001). 
 
Figure 4. Scatterplots showing the correlation between the LLC (log10 transformed) of alpha 
2 cortical sources and the MMSE score in the Nold, ADMCI, and PDMCI subjects as a whole 
group. The Spearman test evaluated the hypothesis of a correlation these LLC and MMSE 
variables (Bonferroni corrected p<0.05). The r and p values are reported within the diagrams. 
 
Figure 5. (Top): Receiver operating characteristic (ROC) curve illustrating the classification of 
the ADMCI and Nold individuals based on interhemispheric LLC in temporal alpha 3 cortical 
sources. The area under the ROC (AUROC) curve was 0.71 indicating a moderate classification 
accuracy of the ADMCI and Nold individuals. (Bottom): ROC curve illustrating the classification 
of the PDMCI and Nold individuals based on the interhemispheric LLC in temporal alpha 2 
cortical sources. The AUROC was 0.72 indicating a moderate classification accuracy of the PDD 
and Nold individuals. 
 
Figure 6. Mean values (± SE) of the interhemispheric (left) and intrahemispheric (right) LLC of 
eLORETA rsEEG cortical sources in whole alpha band for: (1) three Groups (Nold, ADMCI, and 
PDMCI) and (2) five ROI (frontal, central, parietal, occipital, and temporal). 
 
Figure 7. Mean values (± SE) of the intrahemispheric LLC solutions of eLORETA rsEEG cortical 
sources for the three groups (Nold, ADMCI, and PDMCI), the two alpha sub-bands (alpha 2 and 
alpha 3), and (2) the ten pairs of ROIs (frontal-central, frontal-temporal, central-temporal, 
frontal-parietal, central-parietal, temporal-parietal, frontal-occipital, central-occipital, 
temporal-occipital, and parietal-occipital). Legend: FC = frontal-central, FT = frontal-temporal,  
CT = central-temporal, FP = frontal-parietal, CP = central-parietal, TP = temporal-parietal, FO 
= frontal-occipital, CO = central-occipital, TO = temporal-occipital, PO = parietal-occipital. 
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Table 1 
 Nold ADMCI PDMCI Statistical analysis  
N 75 75 75    
Age 
70.1  
(± 0.8 SE) 
70.1  
(± 0.7 SE) 
71.2  
(± 0.8 SE) 
ANOVA: n.s. 
Gender (M/F)  36/39 34/41 38/37 Kruskal-Wallis: n.s. 
Education  
10.2  
(± 0.5 SE) 
10.9  
(± 0.5 SE) 
10.2  
(± 0.6 SE) 
ANOVA: n.s. 
MMSE  
28.5  
(± 0.1 SE) 
25.1  
(± 0.3 SE) 
25.7  
(± 0.3 SE) 
Kruskal-Wallis: 
H= 94.8, p<0.00001 
(Nold>ADMCI, PDMCI) 
 
 







